SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-008942
Filing Date
2023-03-21
Accepted
2023-03-21 16:16:39
Documents
60
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K evok-20221231.htm   iXBRL 10-K 2340185
2 EX-10.27 evok-ex10_27.htm EX-10 40874
3 EX-23.1 evok-ex23_1.htm EX-23 6035
4 EX-31.1 evok-ex31_1.htm EX-31 18158
5 EX-31.2 evok-ex31_2.htm EX-31 18683
6 EX-32.1 evok-ex32_1.htm EX-32 12332
7 EX-32.2 evok-ex32_2.htm EX-32 11796
8 GRAPHIC img214361533_0.jpg GRAPHIC 24883
9 GRAPHIC img214361533_1.jpg GRAPHIC 35101
  Complete submission text file 0000950170-23-008942.txt   7523807

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evok-20221231_def.xml EX-101.DEF 182275
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20221231.xsd EX-101.SCH 51903
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evok-20221231_cal.xml EX-101.CAL 38111
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20221231_lab.xml EX-101.LAB 425149
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20221231_pre.xml EX-101.PRE 306245
54 EXTRACTED XBRL INSTANCE DOCUMENT evok-20221231_htm.xml XML 1049768
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36075 | Film No.: 23749921
SIC: 2834 Pharmaceutical Preparations